Test 2 drugs Flashcards
amantadine
inhibits M2 protein (flu A), for flu treatment, CNS side effects
rimantadine
inhibits M2 protein for flu (A), better than amantadine, less CNS`
oseltamivir
flu - NA inhibitor, prevents release of viral particles, limited use, oral, *GI upset
peramivir
flu - NA inhibitor, prevents release of viral particles, limited use, rash, creatininte, CNS
zanamivir
flu - NA inhibitor, prevents release of viral particles, limited use, inhaled, *bronchospasm
indications for flu treatment
hospital, pregnancy, young and old, medical condition
acyclovir
analog of 2’ deoxyguanosine, requires phosphorylation by virus (X2), works for HSV1/2 and VZV, good CSF
nephrotoxic, CNS
valacyclovir
better available bioavailability
famcyclovir
better for VZV
cidofovir
does not require first phosphorylation step, active against resistant viruses, nucleotide analog, very nephrotoxic
mechanisms of resistance in acyclovir
kinase deficient mutant, mutant that cant phosphorylate, usually in cane hosts, cross resistant
foscarnet
does not require any phosphorylation step, active against resistant viruses, blocks DNA polymerase, CMV and HSV, worse than gancyclovir, nephrotoxic, electrolyte disturbances
gancyclovir
used for CMV, HSV1/2, guanosine derivative, phosphate added by CMV UL97
nephrotoxic, BM suppression
valganciclovir
prodrug of gancyclovir with better bioavailability, prophylaxis of CMV
chloroquine
ion trapping
quinidine
QT prolongation
primaquine
effective against liver stage hypnozoites, forms compounds acting as oxidants, cant be used in G6PD
artemisinin
free radical formation, alkylation, Hb degredation
HIV entry inhibitors
not great, prone to resistance, used in salvage regimens
NRTIs
DNA chain terminators, inhibit mitochondrial replication, lactic acidosis, peripheral neuropathy, lipoatrophy, need phosphorylation
NNRTIs
does not block chain elongation, vivid dreams, not active against HIV2
protease inhibitors
drug interactions, central fat gain, hyperlipidemia, diahrrea
integrase inhibitors
best first line, blocks integrase, few adverse effects
enfuvirtide
entry inhibitor (sounds like fusion, blocks with shield) binds gp41, not great, prone to resistance
maraviroc
entry inhibitor (mare - man on horse with CCR5 banner) binds to CCR5 on T cells, high resistance
abacavir
NRTI - some MI risk, hypersensitivity reaction in HLA-B5701
tenofovir
(Sir Tristan) NRTI - good first line, nephrotoxic and loss of bone marrow density, now delivered as prodrug
lamviudine
(sir lancelot dining) NRTI - treated for HepB, can react when discontinued - given with emtricitabine